Blocking of the mitogen activated protein kinase signal transduction pathway inhibits the proliferation in the prostate cancer cells

GAO Qing-zhen,L Jia-ju,ZHANG Hui,WEI Li-jing,DING Ke-jia
DOI: https://doi.org/10.3969/j.issn.1671-7554.2006.05.018
2006-01-01
Abstract:Objective: To investigate the change of mitogen activated protein kinase(MAPK) signaling pathway during prostate cancer progression,and therefore to explore its role on cell proliferation.Methods: MTT assay was used to examine the effects of epidermal growth factor(EGF) and PD98059 on proliferation of prostate cancer cell lines LNCaP,PC-3 and DU145,and western blotting to detect the level of total extracellular signal-regulated kinase 1/2(ERK1/2),the level of phospho-ERK1/2 before and after the EGF stimulation and PD98059 inhibition.Results: EGF promoted the prostate cancer cell growth,whereas PD98059 inhibited the cell growth and stopped the EGF from stimulating the LNCaP,PC-3 and DU145 cells. The total ERK1/2 level was not significantly different in the three cell lines,whereas the phospho-ERK1/2 was not detected with western blotting in LNCaP cell line and ERK1/2 activity was found in PC-3 and DU145.Conclusion: The MAPK transpass activity is promoted during the prostate cancer progression,suggesting that blocking the MAPK transpass can be used as a method for prostate cancer therapy.
What problem does this paper attempt to address?